Department of Cardiology, Osaka City General Hospital, 2-13-22, Miyakojima-hondori, Miyakojima-ku, Osaka 534-0021, Japan.
Heart. 2010 Nov;96(21):1716-22. doi: 10.1136/hrt.2009.187609.
Myeloperoxidase (MPO) is a leucocyte enzyme that catalyses the formation of a number of reactive oxidant species.
The purpose of this study is to evaluate the relationship between angiographic coronary plaque morphology in patients with unstable angina pectoris (UAP) or stable angina pectoris (SAP) and MPO levels.
Plasma MPO levels on admission were measured in 236 patients with UAP, 146 with SAP and 85 control subjects using an ELISA kit. The angiographic morphology of the culprit lesion was classified into two types, simple or complex, based on the Ambrose classification. In addition, 61 atherectomy specimens obtained from a different cohort of patients with UAP and SAP were studied immunohistochemically for MPO.
Median (IQR) plasma MPO levels in patients with UAP with a complex lesion were significantly higher than in patients with a simple lesion (41.9 (21.7–73.7) ng/ml vs 20.5 (15.9–27.9) ng/ml, p<0.0001), but there was no significant difference between the two groups in patients with SAP. On multivariate analysis, raised plasma MPO levels and Braunwald class III were independent factors for angiographically-detected complex lesions (adjusted OR 12.49, 95% CI 3.24 to 48.17, p=0.0002). In the atherectomy specimens the number of MPO-positive cells in patients with UAP with complex lesions was significantly higher (p<0.0005) than in patients with simple lesions. Moreover, in this cohort, plasma MPO levels were positively correlated with the number of MPO-positive cells in atherectomy specimens (R=0.42, p=0.024).
This study shows that increased expression and plasma MPO levels are closely related to the presence of angiographically-detected complex lesion morphology in patients with UAP.
髓过氧化物酶(MPO)是一种白细胞酶,可催化多种活性氧化剂的形成。
本研究旨在评估不稳定型心绞痛(UAP)或稳定型心绞痛(SAP)患者的血管造影斑块形态与 MPO 水平之间的关系。
使用 ELISA 试剂盒测量了 236 例 UAP 患者、146 例 SAP 患者和 85 例对照患者入院时的血浆 MPO 水平。根据 Ambrose 分类,将罪犯病变的血管造影形态分为简单或复杂两种类型。此外,对来自不同 UAP 和 SAP 患者队列的 61 个经皮冠状动脉介入治疗(PCI)标本进行了 MPO 免疫组织化学研究。
UAP 患者中复杂病变患者的中位(IQR)血浆 MPO 水平明显高于简单病变患者(41.9(21.7-73.7)ng/ml 与 20.5(15.9-27.9)ng/ml,p<0.0001),但 SAP 患者的两组间无显著差异。多变量分析显示,升高的血浆 MPO 水平和 Braunwald Ⅲ级是血管造影检测到的复杂病变的独立因素(调整 OR 12.49,95%CI 3.24-48.17,p=0.0002)。在 PCI 标本中,复杂病变患者的 MPO 阳性细胞数明显高于简单病变患者(p<0.0005)。此外,在该队列中,血浆 MPO 水平与 PCI 标本中 MPO 阳性细胞数呈正相关(R=0.42,p=0.024)。
本研究表明,在 UAP 患者中,MPO 表达增加和血浆 MPO 水平与血管造影检测到的复杂病变形态密切相关。